Progression of cerebral amyloid angiopathy:: Accumulation of amyloid-β40 in affected vessels

被引:161
作者
Alonzo, NC [1 ]
Hyman, BT [1 ]
Rebeck, GW [1 ]
Greenberg, SM [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA
关键词
aging; amyloid; apolipoprotein E; Hemorrhage; stroke;
D O I
10.1097/00005072-199804000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebrovascular deposits of amyloid (cerebral amyloid angiopathy, or CAA) are generally asymptomatic, but in advanced cases, they can lead to vessel rupture and hemorrhage. The process of progression in CAA was studied by comparison of postmortem brains with asymptomatic ("mild") CAA to brains with the form of the disease associated with hemorrhage ("severe CAA"). Cortical and meningeal vessels were immunostained for beta-amyloid and examined by confocal microscopy and by systematic quantitative sampling. We focused on 2 quantitative parameters: the proportion of vessels affected by amyloid (a measure of amyloid seeding of vessels) and the amount of amyloid per affected vessel (a measure of growth of existing lesions). Surprisingly, there was no difference between the proportion of affected cortical vessels in mild and severe CAA (0.29 vs 0.32, p = 0.65), but rather an increase in the area of the 40 amino acid form of beta-amyloid per affected cortical vessel (198.5 +/- 38.7 vs 455.8 +/- 100.9 mu m(2)/vessel, p < 0.007). Increasing doses (from 0 to 1 to 2 copies) of the apolipoprotein E epsilon 4 allele were also associated with greater amyloid per vessel without change in the proportion of affected vessels within each class of CAA severity. These findings suggest that progression from asymptomatic to advanced CAA reflects progressive accumulation of amyloid in vessels previously seeded with amyloid, and that this process is selectively enhanced by apolipoprotein E epsilon 4.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 46 条
  • [1] The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type - Implications for the role of amyloid-beta 1-42 in Alzheimer's disease
    Castano, EM
    Prelli, F
    Soto, C
    Beavis, R
    Matsubara, E
    Shoji, M
    Frangione, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) : 32185 - 32191
  • [2] A WILCOXON-TYPE TEST FOR TREND
    CUZICK, J
    [J]. STATISTICS IN MEDICINE, 1985, 4 (01) : 87 - 90
  • [3] In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics
    Esler, WP
    Stimson, ER
    Ghilardi, JR
    Vinters, HV
    Lee, JP
    Mantyh, PW
    Maggio, JE
    [J]. BIOCHEMISTRY, 1996, 35 (03) : 749 - 757
  • [4] A beta-peptide length and apolipoprotein E genotype in Alzheimer's disease
    Gearing, M
    Mori, H
    Mirra, SS
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 395 - 399
  • [5] A novel presenilin-1 mutation: Increased beta-amyloid and neurofibrillary changes
    GomezIsla, T
    Wasco, W
    Pettingell, WP
    Gurubhagavatula, S
    Schmidt, SD
    Jondro, PD
    McNamara, M
    Rodes, LA
    DiBlasi, T
    Growdon, WB
    Seubert, P
    Schenk, D
    Growdon, JH
    Hyman, BT
    Tanzi, RE
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (06) : 809 - 813
  • [6] Graff-Radford N. R., 1996, Neurology, V46, pA161
  • [7] AMYLOID-BETA PROTEIN (A-BETA) IN ALZHEIMERS-DISEASE BRAIN - BIOCHEMICAL AND IMMUNOCYTOCHEMICAL ANALYSIS WITH ANTIBODIES SPECIFIC FOR FORMS ENDING AT A-BETA-40 OR A-BETA-42(43)
    GRAVINA, SA
    HO, LB
    ECKMAN, CB
    LONG, KE
    OTVOS, L
    YOUNKIN, LH
    SUZUKI, N
    YOUNKIN, SG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) : 7013 - 7016
  • [8] APOLIPOPROTEIN-E EPSILON-4 AND CEREBRAL-HEMORRHAGE ASSOCIATED WITH AMYLOID ANGIOPATHY
    GREENBERG, SM
    REBECK, GW
    VONSATTEL, JPG
    GOMEZISLA, T
    HYMAN, BT
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (02) : 254 - 259
  • [9] GREENBERG SM, 1998, IN PRESS NEUROLOGY
  • [10] A beta 1-40 but not A beta 1-42 levels in cortex correlate with apolipoprotein E epsilon 4 allele dosage in sporadic Alzheimer's disease
    Ishii, K
    Tamaoka, A
    Mizusawa, H
    Shoji, S
    Ohtake, T
    Fraser, PE
    Takahashi, H
    Tsuji, S
    Gearing, M
    Mizutani, T
    Yamada, S
    Kato, M
    StGeorgeHyslop, PH
    Mirra, SS
    Mori, H
    [J]. BRAIN RESEARCH, 1997, 748 (1-2) : 250 - 252